» Authors » Baerbel Hauroeder

Baerbel Hauroeder

Explore the profile of Baerbel Hauroeder including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 35
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaeberich A, Raaz U, Vogt A, Maedgefessel L, Neuhart E, Krezel C, et al.
J Thromb Thrombolysis . 2013 Jul; 37(2):118-30. PMID: 23821043
Efficient and safe anticoagulation is crucial in patients requiring percutaneous coronary intervention (PCI) or extracorporeal circulation during cardiac surgery. Although new anticoagulant strategies have emerged for PCI as alternatives to...
2.
Kaeberich A, Reindl I, Raaz U, Maegdefessel L, Vogt A, Linde T, et al.
J Thromb Thrombolysis . 2011 Jul; 32(4):417-25. PMID: 21773837
Thromboembolism and bleeding after mechanical heart valve replacement are still unsolved problems, particularly for patients requiring anticoagulative bridging therapy. The aim of this study was to investigate whether rivaroxaban, a...
3.
Raaz U, Buerke M, Busshardt M, Maegdefessel L, Plehn A, Hauroeder B, et al.
J Thromb Thrombolysis . 2009 Jun; 29(3):265-70. PMID: 19517216
Owing to its beneficial pharmacological profile, the low-molecular-weight heparin (LMWH) enoxaparin is increasingly being taken as an alternative to UFH in the treatment of ACS with an early invasive strategy...
4.
Maegdefessel L, Linde T, Michel T, Hamilton K, Steinseifer U, Friedrich I, et al.
Thromb Haemost . 2009 Jun; 101(6):1163-9. PMID: 19492162
Prevention of valve thrombosis in patients after prosthetic mechanical heart valve replacement and heparin-induced thrombocytopenia (HIT) is still an open issue. The aim of the present in-vitro study was to...
5.
Maegdefessel L, Buerke M, Schubert S, Reindl I, Michel T, Hauroeder B, et al.
Thromb Haemost . 2008 Oct; 100(4):693-8. PMID: 18841294
Bivalirudin, a direct thrombin inhibitor binds specifically and reversibly to both fibrin-bound and unbound thrombin. Bivalirudin is approved for use as an anticoagulant in patients undergoing percutaneous coronary intervention. The...
6.
Schlitt A, Rupprecht H, Reindl I, Schubert S, Hauroeder B, Carter J, et al.
Coron Artery Dis . 2008 May; 19(4):279-84. PMID: 18480673
Background: The Organization to Assess Strategies in Acute Ischemic Syndromes trials showed that fondaparinux (fonda) is at least as effective and safe as unfractionated heparin (UFH) and enoxaparin (enoxa) in...
7.
Schlitt A, Hamilton K, Maegdefessel L, Dahm M, Theis C, Eichler M, et al.
J Heart Valve Dis . 2006 Dec; 15(6):809-14. PMID: 17152789
Background And Aim Of The Study: The study aim was to investigate the efficacy of three different anticoagulants in preventing thrombus formation on mechanical heart valves, using an in-vitro system....
8.
Schroeder J, Gelderblom H, Hauroeder B, Schmetz C, Milios J, Hofstaedter F
Micron . 2006 Jul; 37(6):577-90. PMID: 16843832
The purpose of this study was to explore the turnaround times, section and image quality of a number of more "difficult" specimens destined for rapid diagnostic electron microscopy (EM) after...
9.
Schlitt A, Buerke M, Hauroeder B, Peetz D, Hundt F, Bickel C, et al.
Thromb Haemost . 2003 Jul; 90(2):245-51. PMID: 12888871
The aim of the present study was to investigate the efficacy of three different parenterally administered anticoagulants for the prevention of thrombus formation on artificial heart valves in an experimental...